Primaquine–quinoxaline 1,4‑di‑N‑oxide hybrids with action on the exo‑erythrocytic forms of Plasmodium induce their efect by the production of reactive oxygen species

Background: The challenge in anti-malarial chemotherapy is based on the emergence of resistance to drugs and the search for medicines against all stages of the life cycle of Plasmodium spp. as a therapeutic target. Nowadays, many molecules with anti-malarial activity are reported. However, few stu...

Full description

Bibliographic Details
Main Authors: Bonilla‑Ramírez, L. (Leonardo), Galiano, S. (Silvia), Quiliano, M. (Miguel), Aldana, I. (Ignacio), Pabon, A. (Adriana)
Format: info:eu-repo/semantics/article
Language:eng
Published: Springer Science and Business Media LLC 2022
Subjects:
Online Access:https://hdl.handle.net/10171/63629
_version_ 1793400397455425536
author Bonilla‑Ramírez, L. (Leonardo)
Galiano, S. (Silvia)
Quiliano, M. (Miguel)
Aldana, I. (Ignacio)
Pabon, A. (Adriana)
author_facet Bonilla‑Ramírez, L. (Leonardo)
Galiano, S. (Silvia)
Quiliano, M. (Miguel)
Aldana, I. (Ignacio)
Pabon, A. (Adriana)
author_sort Bonilla‑Ramírez, L. (Leonardo)
collection DSpace
description Background: The challenge in anti-malarial chemotherapy is based on the emergence of resistance to drugs and the search for medicines against all stages of the life cycle of Plasmodium spp. as a therapeutic target. Nowadays, many molecules with anti-malarial activity are reported. However, few studies about the cellular and molecular mechanisms to understand their mode of action have been explored. Recently, new primaquine-based hybrids as new molecules with potential multi-acting anti-malarial activity were reported and two hybrids of primaquine linked to quinoxaline 1,4-di-N-oxide (PQ–QdNO) were identifed as the most active against erythrocytic, exoerythrocytic and sporogonic stages. Methods: To further understand the anti-malarial mode of action (MA) of these hybrids, hepg2-CD81 were infected with Plasmodium yoelii 17XNL and treated with PQ–QdNO hybrids during 48 h. After were evaluated the production of ROS, the mitochondrial depolarization, the total glutathione content, the DNA damage and proteins related to oxidative stress and death cell. Results: In a preliminary analysis as tissue schizonticidals, these hybrids showed a mode of action dependent on peroxides production, but independent of the activation of transcription factor p53, mitochondrial depolarization and arrest cell cycle. Conclusions: Primaquine–quinoxaline 1,4-di-N-oxide hybrids exert their antiplasmodial activity in the exoeryth‑ rocytic phase by generating high levels of oxidative stress which promotes the increase of total glutathione levels, through oxidation stress sensor protein DJ-1. In addition, the role of HIF1a in the mode of action of quinoxaline 1,4-diN-oxide is independent of biological activity.
format info:eu-repo/semantics/article
id oai:dadun.unav.edu:10171-63629
institution Universidad de Navarra
language eng
publishDate 2022
publisher Springer Science and Business Media LLC
record_format dspace
spelling oai:dadun.unav.edu:10171-636292022-06-10T01:05:12Z Primaquine–quinoxaline 1,4‑di‑N‑oxide hybrids with action on the exo‑erythrocytic forms of Plasmodium induce their efect by the production of reactive oxygen species Bonilla‑Ramírez, L. (Leonardo) Galiano, S. (Silvia) Quiliano, M. (Miguel) Aldana, I. (Ignacio) Pabon, A. (Adriana) Malaria Plasmodium Exoerythrocytic stage Quinoxaline 1 4-Di-N-oxide Cell death Oxide stress Background: The challenge in anti-malarial chemotherapy is based on the emergence of resistance to drugs and the search for medicines against all stages of the life cycle of Plasmodium spp. as a therapeutic target. Nowadays, many molecules with anti-malarial activity are reported. However, few studies about the cellular and molecular mechanisms to understand their mode of action have been explored. Recently, new primaquine-based hybrids as new molecules with potential multi-acting anti-malarial activity were reported and two hybrids of primaquine linked to quinoxaline 1,4-di-N-oxide (PQ–QdNO) were identifed as the most active against erythrocytic, exoerythrocytic and sporogonic stages. Methods: To further understand the anti-malarial mode of action (MA) of these hybrids, hepg2-CD81 were infected with Plasmodium yoelii 17XNL and treated with PQ–QdNO hybrids during 48 h. After were evaluated the production of ROS, the mitochondrial depolarization, the total glutathione content, the DNA damage and proteins related to oxidative stress and death cell. Results: In a preliminary analysis as tissue schizonticidals, these hybrids showed a mode of action dependent on peroxides production, but independent of the activation of transcription factor p53, mitochondrial depolarization and arrest cell cycle. Conclusions: Primaquine–quinoxaline 1,4-di-N-oxide hybrids exert their antiplasmodial activity in the exoeryth‑ rocytic phase by generating high levels of oxidative stress which promotes the increase of total glutathione levels, through oxidation stress sensor protein DJ-1. In addition, the role of HIF1a in the mode of action of quinoxaline 1,4-diN-oxide is independent of biological activity. 2022-06-09T12:04:24Z 2022-06-09T12:04:24Z 2019 info:eu-repo/semantics/article 10.1186/s12936-019-2825-8 https://hdl.handle.net/10171/63629 eng info:eu-repo/semantics/openAccess application/pdf Springer Science and Business Media LLC
spellingShingle Malaria
Plasmodium
Exoerythrocytic stage
Quinoxaline 1
4-Di-N-oxide
Cell death
Oxide stress
Bonilla‑Ramírez, L. (Leonardo)
Galiano, S. (Silvia)
Quiliano, M. (Miguel)
Aldana, I. (Ignacio)
Pabon, A. (Adriana)
Primaquine–quinoxaline 1,4‑di‑N‑oxide hybrids with action on the exo‑erythrocytic forms of Plasmodium induce their efect by the production of reactive oxygen species
title Primaquine–quinoxaline 1,4‑di‑N‑oxide hybrids with action on the exo‑erythrocytic forms of Plasmodium induce their efect by the production of reactive oxygen species
title_full Primaquine–quinoxaline 1,4‑di‑N‑oxide hybrids with action on the exo‑erythrocytic forms of Plasmodium induce their efect by the production of reactive oxygen species
title_fullStr Primaquine–quinoxaline 1,4‑di‑N‑oxide hybrids with action on the exo‑erythrocytic forms of Plasmodium induce their efect by the production of reactive oxygen species
title_full_unstemmed Primaquine–quinoxaline 1,4‑di‑N‑oxide hybrids with action on the exo‑erythrocytic forms of Plasmodium induce their efect by the production of reactive oxygen species
title_short Primaquine–quinoxaline 1,4‑di‑N‑oxide hybrids with action on the exo‑erythrocytic forms of Plasmodium induce their efect by the production of reactive oxygen species
title_sort primaquine–quinoxaline 1,4‑di‑n‑oxide hybrids with action on the exo‑erythrocytic forms of plasmodium induce their efect by the production of reactive oxygen species
topic Malaria
Plasmodium
Exoerythrocytic stage
Quinoxaline 1
4-Di-N-oxide
Cell death
Oxide stress
url https://hdl.handle.net/10171/63629
work_keys_str_mv AT bonillaramirezlleonardo primaquinequinoxaline14dinoxidehybridswithactionontheexoerythrocyticformsofplasmodiuminducetheirefectbytheproductionofreactiveoxygenspecies
AT galianossilvia primaquinequinoxaline14dinoxidehybridswithactionontheexoerythrocyticformsofplasmodiuminducetheirefectbytheproductionofreactiveoxygenspecies
AT quilianommiguel primaquinequinoxaline14dinoxidehybridswithactionontheexoerythrocyticformsofplasmodiuminducetheirefectbytheproductionofreactiveoxygenspecies
AT aldanaiignacio primaquinequinoxaline14dinoxidehybridswithactionontheexoerythrocyticformsofplasmodiuminducetheirefectbytheproductionofreactiveoxygenspecies
AT pabonaadriana primaquinequinoxaline14dinoxidehybridswithactionontheexoerythrocyticformsofplasmodiuminducetheirefectbytheproductionofreactiveoxygenspecies